Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice

Human Molecular Genetics

Volumn 19, Issue 15, 2010, Pages 3021-3029

  Rantakari, Pia ^a   Nikkilä, Jenni ^b   Jokela, Heli ^a   Ola, Roxana ^c   Pylkäs, Katri ^b   Lagerbohm, Heidi ^a   Sainio, Kirsi ^c   Poutanen, Matti ^a   Winqvist, Robert ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PALB2 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL TISSUE; ARTICLE; BLASTOCYST; BRCA2 GENE; DNA DAMAGE; EMBRYO; EMBRYO DEVELOPMENT; GASTRULATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HOMOZYGOSITY; IN VITRO STUDY; KNOCKOUT MOUSE; LETHALITY; MESODERM; MOUSE; MUTANT; NONHUMAN; ONCOGENE; P21 GENE; P53 GENE; PALB2 GENE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; ANIMAL EMBRYO; CELL DIFFERENTIATION; EMBRYO DEATH; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HETEROZYGOTE; METABOLISM; MUTATION; PATHOLOGY;

MUS;

ANIMALS; BIOLOGICAL MARKERS; BLASTOCYST; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EMBRYO LOSS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; HETEROZYGOTE; MESODERM; MICE; MUTATION; TUMOR SUPPRESSOR PROTEINS;

EID: 77957332124     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq207     Document Type: Article

References (34)

1. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitman, A., Billia, F. et al. (1996) The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell, 85, 1009-1023.
2. Hakem, R., de la Pompa, J.L. and Mak, T.W. (1998) Developmental studies of Brca1 and Brca2 knock-out mice. J. Mammary Gland Biol. Neoplasia, 3, 431-445.
3. Suzuki, A., de la Pompa, J.L., Hakem, R., Elia, A., Yoshida, R., Mo, R., Nishina, H., Chuang, T., Wakeham, A., Itie, A. et al. (1997) Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev., 11, 1242-1252.
4. Sy, S.M., Huen, M.S., Zhu, Y. and Chen, J. (2009) PALB2 regulates recombinational repair through chromatin association and oligomerization. J. Biol. Chem., 284, 18302-18310.
5. Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F.J. and Livingston, D.M. (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell., 22, 719-729.
6. Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B. and Yu, X. (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr. Biol., 19, 524-529.
7. Sy, S.M., Huen, M.S. and Chen, J. (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc. Natl Acad. Sci. USA, 106, 7155-7160.
8. Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freud, M. et al. (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet., 39, 162-164.
9. Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet., 39, 165-167.
10. Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A., Pylkäs, K., Karppinen, S.M., Rapakko, K. et al. (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature, 446, 316-319.
11. Foulkes, W.D., Ghadirian, P., Akbari, M.R., Hamel, N., Giroux, S., Sabbaghian, N., Darnel, A., Royer, R., Poll, A., Fafard, E. et al. (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res., 9, R83.
12. Tischkowitz, M., Xia, B., Sabbaghian, N., Reis-Filho, J.S., Hamel, N., Li, G., van Beers, E.H., Li, L., Khalil, T., Quenneville, L.A. et al. (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc. Natl Acad. Sci. USA, 104, 6788-6793.
13. Garcia, M.J. and Benitez, J. (2008) The Fanconi anaemia/BRCA pathway and cancer susceptibility searching for new therapeutic targets. Clin. Transl. Oncol., 10, 78-84.
14. Cao, A.Y., Huang, J., Hu, Z., Li, W.F., Ma, Z.L., Tang, L.L., Zhang, B., Su, F.X., Zhou, J., Di, G.H. et al. (2009) The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res. Treat., 114, 457-462.
15. Erkko, H., Dowty, J.G., Nikkilä, J., Syrjäkoski, K., Mannermaa, A., Pylkäs, K., Southey, M.C., Holli, K., Kallioniemi, A., Jukkola-Vuorinen, A. et al. (2008) Penetrance analysis of the PALB2 c.1592delT founder mutation. Clin. Cancer Res., 14, 4667-4671.
16. Sluiter, M., Mew, S. and van Rensburg, E.J. (2009) PALB2 sequence variants in young South African breast cancer patients. Fam. Cancer, 8, 347-353.
17. Dansonka-Mieszkowska, A., Kluska, A., Moes, J., Dabrowska, M., Nowakowska, D., Niwinska, A., Derlatka, P., Cendrowski, K. and Kupryjanczyk, J. (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med. Genet., 11, 20.
18. Papi, L., Putignano, A.L., Congregati, C., Piaceri, I., Zanna, I., Sera, F., Morrone, D., Genuardi, M. and Palli, D. (2009) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam. Cancer [Epub ahead of print].
19. Jones, S., Hruban, R.H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D.W., Lin, J.C., Palmisano, E., Brune, K., Jaffee, E.M. et al. (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science, 324, 217.
20. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
21. Xia, B., Dorsman, J.C., Ameziane, N., de Vries, Y., Rooimans, M.A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J. et al. (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet., 39, 159-161.
22. Joenje, H. and Patel, K.J. (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet., 2, 446-457.
23. Kutler, D.I., Singh, B., Satagopan, J., Batish, S.D., Berwick, M., Giampietro, P.F., Hanenberg, H. and Auerbach, A.D. (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood, 101, 1249-1256.
24. Liu, C.Y., Flesken-Nikitin, A., Li, S., Zeng, Y. and Lee, W.H. (1996) Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev., 10, 1835-1843.
25. Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K. and Koller, B.H. (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet., 12, 191-194.
26. Evers, B. and Jonkers, J. (2006) Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene, 25, 5885-5897.
27. Power, M.A. and Tam, P.P. (1993) Onset of gastrulation, morphogenesis and somitogenesis in mouse embryos displaying compensatory growth. Anat. Embryol. (Berl.), 187, 493-504.
28. Tam, P.P. and Behringer, R.R. (1997) Mouse gastrulation: the formation of a mammalian body plan. Mech. Dev., 68, 3-25.
29. Goh, K.L., Yang, J.T. and Hynes, R.O. (1997) Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos. Development, 124, 4309-4319.
30. Westfall, M.D., Mays, D.J., Sniezek, J.C. and Pietenpol, J.A. (2003) The delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by hay-wells syndrome-derived mutations. Mol. Cell Biol., 23, 2264-2276.
31. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) P21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.
32. Connor, F., Bertwistle, D., Mee, P.J., Ross, G.M., Swift, S., Grigorieva, E., Tybulewicz, V.L. and Ashworth, A. (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet., 17, 423-430.
33. Patel, K.J., Yu, V.P., Lee, H., Corcoran, A., Thistlethwaite, F.C., Evans, M.J., Colledge, W.H., Friedman, L.S., Poder, B.A. and Venkitaraman, A.R. (1998) Involvement of Brca2 in DNA repair. Mol. Cell, 1, 347-357.
34. Wilkinson, D. and Green, P. (1990) In Situ hybridization and threedimensional reconstruction of serial sections. In: postimplantation mammalian embryos. A practical approach. Copp, A. and Cockroft, D. (eds), Oxford University Press, London, pp. 155-171.